© CBM

Pakistan eliminates trachoma as a public health concern

On October 1, 2024, Pakistan marked a historic achievement. The World Health Organization (WHO) officially recognised Pakistan as having eliminated trachoma as a public health concern. With this milestone, Pakistan joins 19 nations globally and becomes the sixth in the Eastern Mediterranean Region to achieve this status.

What does trachoma elimination mean?

Trachoma, a neglected tropical disease (NTD) and the world’s leading cause of preventable blindness, primarily affects poor rural communities lacking clean water, sanitation, and healthcare. Elimination means the disease is no longer a public health threat. Specifically, Pakistan met WHO’s strict criteria, demonstrating that trachoma prevalence has been reduced to safe levels.

Consultation workshop for the development of Pakistans trachoma elimination dossier. © CBM
Consultation workshop for the development of Pakistans trachoma elimination dossier.

The two-decade journey to elimination

Pakistan’s fight against trachoma began in the 1950s with a control program under the Ministry of Health. However, the program was discontinued in the 1970s without achieving its goals due to resource constraints.

In the early 2000s, under the leadership of Prof. Mohammad Daud Khan, the fight against trachoma was revived. The WHO identified Pakistan as a priority country for its Global Elimination of Trachoma 2020 (GET 2020) initiative. In 2002, a National Trachoma Rapid Assessment (TRA) identified high-prevalence areas, leading to the establishment of the National Trachoma Task Force (NTTF).

 

 

The NTTF implemented the WHO SAFE strategy:

  • Surgery to treat trichiasis (advanced trachoma).
  • Antibiotics (azithromycin) to eliminate infection.
  • Face washing for improved hygiene.
  • Environmental improvements to reduce disease transmission.

Over two decades, the program trained trichiasis surgeons, mobilised resources, and launched community education campaigns. These efforts significantly reduced the prevalence of trachoma, improving eye health outcomes for millions in Pakistan.

Acknowledging the leaders who contributed to this milestone

The program’s success is credited to sustained leadership and collaboration:

  • Prof. Mohammad Daud Khan laid the foundation for elimination efforts.
  • Prof. Asad Aslam Khan, who succeeded Prof. Daud Khan, led the program to its conclusion as Chair of the NTTF.
  • Dr Zahid Hussain Awan, CBM IEH Project Manager CBM, who has been part of the trachoma elimination journey in Pakistan since 2000, has been instrumental in mobilising resources, implementing interventions, and driving community engagement, ensuring that critical health services reached even the most underserved communities, leading us to this proud milestone of elimination.
  • Dr. Mohammed Babar Qureshi, CBM Director of the Inclusive Health Initiative, was the first National Field Coordinator and Secretary of the National Trachoma Task Force. He led Pakistan's first National Trachoma Rapid Assessment and designed the SAFE strategy for the National Trachoma Control Programme, which lasted two decades. In his roles with the Trachoma Expert Committee, EMR Alliance for Trachoma Control, and IAPB, he provided technical guidance that led to the certification of Trachoma elimination as a public health issue in Pakistan, supported by the contributions of CBM teams in the Regional and Country Offices.

International partners, including CBM, Fred Hollows Foundation, Sightsavers, and corporate donors, played a crucial role. The active participation of Pakistani communities in awareness campaigns, treatment, and prevention efforts was essential for eventual elimination.

A collaborative success

The success demonstrates the strength of partnerships among the public, private, non-government, and community. When these groups work together, they can effectively promote awareness campaigns, treatment initiatives, and healthier practices, ultimately achieving elimination goals.

Know more about our work with NTDs

  • CBM NTD Annual Report 2024

    pdf7.3MB, Accessible

    In 2023, CBM made a remarkable impact, reaching an unprecedented number of people by delivering life-changing services focused on trachoma, onchocerciasis, lymphatic filariasis, soil-transmitted worm infections and schistosomiasis. We successfully reached 54.1 million community members, providing them with much-needed care and support. Our commitment to preventive measures was demonstrated through the administration of 88.7 million doses of preventive chemotherapy, significantly reducing the burden of NTDs in high-risk communities

    Download